Peptide Decoding
New?New to peptides?Start here →
Decoding

Acetyl Tetrapeptide-15 (Skinasensyl)_Dosage, benefits & legal status

Also known as Skinasensyl, Skinasensyl LS 9749, Skinasensyl PW LS 9852, Ac-YPFF-NH2, Ac-Tyr-Pro-Phe-Phe-NH2

Published October 21, 2026

An acetyl-capped copy of endomorphin-2, an opioid peptide, sold by BASF as Skinasensyl to make reactive skin less easily irritated. Its only data are supplier tests published without numbers.

Less reactive skinEndomorphin-derived cosmetic peptide (acetylated, amidated tetrapeptide)Cosmetic
DoseBASF use level not public; 0.0015% in the supplier's volunteer test (2021 review)
FrequencyTwice daily (supplier test)
RouteOn the skin (cream or serum)
StatusCosmetic ingredient
CycledDaily use

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Acetyl Tetrapeptide-15 (Skinasensyl)?

Plain language first. The technical label stays, but it never stands alone.

Overview

It is a soothing ingredient in creams, serums and cleansers for sensitive skin, including lines such as Bioderma Sensibio Tolerance+ and Dermalogica UltraCalming, so many people with reactive skin already use it. The best evidence is a supplier test in 20 volunteers: after a 0.0015% solution twice a day for 4 days, it took more capsaicin, the compound that makes chili peppers hot, to cause discomfort, but no numbers were published. It is built from an opioid peptide, yet no study shows it does anything beyond the skin, and a 2021 review found no studies of it in the scientific literature.

The technical version

Acetyl tetrapeptide-15 is Ac-Tyr-Pro-Phe-Phe-NH2: endomorphin-2, an opioid peptide, with an acetyl cap on its first residue. It was introduced in 2008 as Skinasensyl by Laboratoires Sérobiologiques, then the active-ingredients business of Cognis, and is now sold by BASF; the supplier says it acts on µ-opioid receptors on skin nerve endings to cut release of the neuropeptide CGRP and raise the threshold at which skin feels discomfort. Those results come only from supplier tests described without effect sizes, no binding affinity or potency has been published for the acetylated peptide, and a 2021 review found no studies of it in the scientific literature.

What it's used for

A cosmetic ingredient in soothing creams, serums, cleansers and hair conditioners for sensitive or reactive skin, listed in 40 products on one ingredient database and more than 50 on another. Used only on the skin.

02

How does Acetyl Tetrapeptide-15 (Skinasensyl) work?

What it does in the body, and where.

Acetyl tetrapeptide-15 is endomorphin-2, an opioid peptide, with an acetyl cap, and its supplier says it calms skin through opioid receptors on sensory nerve endings.

  1. 01
    An opioid peptide, capped
    In 1997 Zadina and colleagues reported endomorphin-1, isolated from brain, as a potent and selective natural activator of the µ-opioid receptor, and also isolated endomorphin-2 (Tyr-Pro-Phe-Phe-NH2), one residue different. Acetyl tetrapeptide-15 is endomorphin-2 with an acetyl group on its first tyrosine. No binding affinity or potency for the acetylated form has been published.
  2. 02
    Less nerve signal released
    Sensory nerve cells release a signaling peptide called CGRP when stimulated. In supplier tests described by a 2021 review, cells treated for 6 hours with 0.001% of the peptide released less CGRP after stimulation with potassium chloride and capsaicin, doing better than capsazepine, a capsaicin-receptor blocker, and about as well as the calcium-channel blocker verapamil. Naloxone, an opioid-receptor blocker, weakened the effect. No percentages or p-values were published.
  3. 03
    A higher discomfort threshold
    The supplier links this to a higher threshold before skin feels discomfort, from its capsaicin test in 20 volunteers. No data show whether the peptide passes through the skin, how long it lasts there or whether any reaches the blood, and no study shows any effect beyond the skin.
Anatomical illustration highlighting skin
WHERE THIS COMPOUND IS THOUGHT TO ACT:
Skin

03

What else is it used for?

Each group carries its own evidence level.

Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

Supplier nerve-cell test

Supplement or cosmetic
  • Lab studySensory neurons were incubated for 6 hours with 0.0003% or 0.001% of the peptide, capsazepine 10 µM or verapamil 100 µM, then stimulated with potassium chloride and capsaicin.
  • Lab studyThe review reports that 0.001% cut CGRP release very significantly, better than capsazepine and similar to verapamil, and that naloxone, an opioid-receptor blocker, weakened the effect.
  • No dataNo percentages or p-values are given, and the data trace back to supplier marketing material.

Supplier volunteer test

Supplement or cosmetic
  • human-early20 volunteers, split-face and single-blind: capsaicin on the folds beside the nose set the dose that caused discomfort, then a 0.0015% solution went on one side of the face and vehicle on the other, twice daily for 4 days, before the challenge was repeated.
  • human-earlyThe review reports a significant increase in the capsaicin dose that provoked discomfort, with no effect size, p-value or responder rate.
  • No dataNo randomization is described, the vehicle side is the only comparison, and the review does not say the volunteers had sensitive skin; it names a different peptide as the only one tested in sensitive-skin volunteers.

Independent research

none
  • ReviewA 2021 review of peptides in sensitive-skin products found no studies of this compound in the scientific literature; its sources for the supplier data are a BASF web page and two trade-press articles.
  • Lab studyThe only independent paper found, a 2016 chemistry study from Adam Mickiewicz University in Poland, describes a related compound, the same four-residue chain with jasmonic acid in place of the acetyl cap (JA-YPFF-NH2); its abstract reports no biological testing.

How widely it is used

Supplement or cosmetic
  • ReviewOf 88 facial products for sensitive skin from multinational brands, 15 (about 17%) contained peptides, 7 distinct ones; acetyl tetrapeptide-15 was the third most used, after acetyl dipeptide-1 cetyl ester and palmitoyl tripeptide-8.
  • ReviewIngredient databases list it in 40 to more than 50 products, including Bioderma Sensibio Tolerance+ and Dermalogica UltraCalming Serum Concentrate; these databases are user-built and not complete.
Often left out

It is correctly described as derived from endomorphin-2: it is endomorphin-2 (Tyr-Pro-Phe-Phe-NH2) with an acetyl cap. Some distributor pages give the sequence as N-acetyl-Tyr-Pro-Phe-NH2, three residues; the correct sequence has four, Ac-Tyr-Pro-Phe-Phe-NH2, as FDA's substance registry, the review and Cayman give it. A 2021 review is reported to describe supplier testing in 20 volunteers, and it does: a split-face, single-blind test with no published effect size, in volunteers the review does not describe as having sensitive skin. Its authors are reported to have found independent clinical research lacking; their wording is broader, that no studies were found in the scientific literature for this compound at all. One evidence-rating site grades it as backed by one randomized trial or several controlled studies, cites a Cosmetic Ingredient Review safety assessment and rates it safe in pregnancy; no randomized trial has been published, no such assessment was found, and no pregnancy data exist. Despite the similar names, acetyl tetrapeptide-2 and acetyl tetrapeptide-11, also on this site, are different molecules; the INCI numbers do not signal a family.

The published record

Research index

1

Papers and trials about Acetyl Tetrapeptide-15 (Skinasensyl)

Furthest stage reached: No clinical trial on record

Compare this against the whole library →

In animals0
In the lab0
Reviews1
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

Acetyl Tetrapeptide-15 (Skinasensyl) vial rendering
Compound field notes

At a glance

Four things to know about Acetyl Tetrapeptide-15 (Skinasensyl)

01

Evidence

Cosmetic

02

Category

Skin and cosmetic

03

Common vial

Varies

04

Half-life

Not established

04

How much, and do you cycle it?

The range, and whether you take breaks.

BASF use level not public; 0.0015% in the supplier's volunteer test (2021 review), twice daily (supplier test). Daily use Community practice

Applied daily like other cosmetic actives. The supplier's volunteer test used it twice a day for 4 days.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Not establishedNo figure

Applied to the skin. No skin-penetration, stability or blood-level data have been published, so whether any reaches the bloodstream is not known.

You can compare this against the whole library to see where it sits.

06

What does it cost?

Typical dose and cost, in plain numbers.

Acetyl Tetrapeptide-15 (Skinasensyl) is not injected

It is taken on the skin (cream or serum). A cosmetic ingredient in creams, serums, cleansers and hair conditioners. BASF's recommended use level for both Skinasensyl grades is not public, and neither is the peptide content of either grade, so the amount of peptide in a product cannot be worked out and the calculator has no range to draw. As a 2021 review describes them, the supplier's lab tests used 0.0003% and 0.001%, and its volunteer test a 0.0015% solution twice daily for 4 days; the review does not say whether these are percentages of pure peptide or of the trade grade. One reseller says its own powder, sold as Pep-Sensyl, holds 1,500 ppm peptide and lists a use rate of 0.3 to 1%; BASF has not published either figure. There is no oral or injected dose.

Cost per month
—
Cost per dose
—
Typical dose
—Community practice
07

How do you store it?

Before mixing, and after.

Room temperature, out of light. Cap it tight after each use.

Acetyl Tetrapeptide-15 (Skinasensyl) ships as a cream, gel, or serum. Keep it at room temperature away from sun and heat unless the label says otherwise. Refrigerating an emulsion can split the texture. Watch for color, smell, or separation changes and stop using it if any appear.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Not studied in any published trial: the only human data are a supplier test in 20 volunteers, described without numbers, and the review that reports it does not say they had sensitive skin
  • Not studied by injection or by mouth: it is sold as a skin-care ingredient and as a lab reagent, and no study has looked at its effects inside the body
  • Not studied in pregnancy: a pregnancy rating of safe that circulates online gives no data
  • Known sensitivity to a product that contains it

Stop and get help

These are emergencies. Seek care.
  • Redness, burning, itching or a rash where it is applied

Common effects

Expected, and usually mild.
  • No side effects of the peptide have been reported in any published source, supplier or independent
  • No tolerance results from the supplier's 4-day test in 20 volunteers have been published
  • No repeated patch test, irritation or sensitization study has been published, and no Cosmetic Ingredient Review safety assessment was found
  • One online rating of low irritation and allergy potential gives no data; the Cosmetic Ingredient Review assessment it lists as a source could not be found

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Acetyl Tetrapeptide-15 (Skinasensyl) approved?

And where the numbers on this page come from.

Not as a medicine. Acetyl Tetrapeptide-15 (Skinasensyl) is sold without a prescription as a cosmetic ingredient, which is a different thing from being approved as a drug.

What has happened recently

A cosmetic ingredient, not a drug, with no drug approval, designation, IND or clinical-trial registration found anywhere. Ingredient databases citing the EU cosmetic ingredient database (CosIng) give it ID 85459 with the function skin conditioning; whether CosIng lists any restriction is not established. FDA's substance registry gives it UNII 6K389LE0MV and lists the brand name Skinasensyl, and it appears in 12 labels on DailyMed, all over-the-counter sunscreens or tinted SPF creams in which sunscreen filters are the active ingredients. No Cosmetic Ingredient Review safety assessment was found. Laboratoires Sérobiologiques, the active-ingredients business of Cognis Care Chemicals, launched it with trade-press coverage in December 2008 in two grades: a liquid, Skinasensyl LS 9749 (in water, glycerin and coco-glucoside, preserved with sorbic acid), and a preservative-free powder, Skinasensyl PW LS 9852 (in mannitol and sodium citrate). Both grades are now sold by BASF. Research-grade material is sold as a lab reagent, not as a cosmetic.

10

What else is like Acetyl Tetrapeptide-15 (Skinasensyl)?

Others in Skin and cosmetic, side by side.

If you're weighing Acetyl Tetrapeptide-15 (Skinasensyl), it's worth reading Acetyl Tetrapeptide-2 (Thymulen 4), Acetyl Tetrapeptide-3, and Acetyl Tetrapeptide-5 (Eyeseryl) in the same class.

Guides for this compound

Sources

Beyond these, 1 records are indexed. Browse the records